Despite already being approved for these patients, investors should care because the company is seeking to expand its supplemental New Drug Application [sNDA] label to include patients as young as ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sonida Senior Living, Inc. ("Sonida" or the "Company") (NYSE: SNDA), a leading owner, operator and investor in senior living ...

The sNDA submission is supported by positive results from two late-stage studies, Studies 501 and 502, that evaluated 42 mg of lumateperone as an adjunctive therapy to antidepressants for MDD ...

SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced the Company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and ...

A SUBORDINATION, Non-Disturbance and Attornment Agreement, or SNDA, is an agreement among a tenant, a landlord, and the landlord’s lender. The landlord’s lender, or mortgagee, is the bank ...

How so? Well, the FDA not only accepted its supplemental New Drug Application [sNDA] of Cabometyx for the treatment of patients with advanced neuroendocrine tumors [NET], but gave a PDUFA date of ...

Alnylam Pharmaceuticals Inc. ALNY said Monday it would no longer pursue its supplemental new drug application (sNDA) for patisiran as a treatment for the cardiomyopathy of transthyretin-mediated ...